Juvenile Idiopathic Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Idiopathic Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-06-03FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
FDA approval · 2010-04-26FDA Approved: ZYBIC — Supplemental Application (Redmont Pharmaceuticals, LLC)
FDA approved a supplemental application for ZYBIC (meloxicam) submitted by Redmont Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2010-01-11Clinical Trial Update: Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA) [Phase 3]
A Phase 3 trial evaluating adalimumab (Humira) in children with polyarticular juvenile idiopathic arthritis has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Juvenile Rheumatoid Arthritis [Phase 2]
Amgen has completed a Phase 2 clinical trial for juvenile idiopathic arthritis.
-
FDA approval · 2009-09-24FDA Approved: MELOXICAM — Supplemental Application (Carlsbad Technology, Inc.)
The FDA approved a supplemental application for Meloxicam from Carlsbad Technology, Inc., indicating the supplemental action for the generic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-18Clinical Trial Update: Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain
A Spain-based study evaluating etanercept in rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis has completed; spo…
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
A completed clinical trial evaluating cyclosporine A for Juvenile Idiopathic Arthritis-associated chronic anterior uveitis.
-
FDA approval · 2009-05-13FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for CIMZIA (certolizumab pegol) submitted by UCB, Inc.
-
CLINICAL_TRIALS other · 2008-12-03Clinical Trial Update: Magnetic Resonance Imaging Follow-up on Temporomandibular Arthritis in Children With Juvenile Idiopathic Arthritis
Update on a magnetic resonance imaging follow-up study of temporomandibular arthritis in children with juvenile idiopathic arthritis; the cu…
-
CLINICAL_TRIALS research · 2008-12-02Clinical Trial Update: Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)
This clinical trial update discusses the use of magnetic resonance imaging (MRI) in asymptomatic patients with Juvenile Idiopathic Arthritis…
-
CLINICAL_TRIALS trial_result · 2008-08-27Clinical Trial Update: Infliximab to Treat Children With Juvenile Rheumatoid Arthritis [Phase 2]
A Phase 2 study evaluating infliximab for juvenile idiopathic arthritis in children was terminated.
-
FDA approval · 2008-07-31FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for Tolmetin Sodium from Atland Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2008-05-30Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA [Phase 3]
A Phase 3 trial comparing celecoxib suspension to naproxen suspension in juvenile arthritis has completed, evaluating efficacy and safety.
-
FDA approval · 2008-04-07FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Orencia (abatacept) submitted by E.R. Squibb & Sons, L.L.C., resulting in an update to its l…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis [Phase 1]
Phase 1 trial evaluating the safety and efficacy of chicken type II collagen for uveitis in patients with juvenile idiopathic arthritis.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis [Phase 2]
Phase 2 trial evaluating TNRF:Fc for eye inflammation in juvenile idiopathic arthritis and uveitis has completed.
-
FDA approval · 2008-01-14FDA Approved: CELEBREX — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Celebrex (celecoxib) submitted by Viatris Specialty LLC to update the product labeling under NDA…
-
FDA approval · 2007-11-20FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Meloxicam filed by Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2007-11-07FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen (generic Naproxen) from Hikma Pharmaceuticals USA Inc., resulting in approval of a gene…
-
FDA approval · 2007-10-25FDA Approved: MELOXICAM — Supplemental Application (AiPing Pharmaceutical, Inc)
FDA approved a supplemental application for MELOXICAM from AiPing Pharmaceutical, Inc., resulting in the availability of a generic meloxicam…
-
FDA approval · 2007-10-16FDA Approved: MELOXICAM — Supplemental Application (Terrain Pharmaceuticals, Inc.)
The FDA approved a supplemental application for meloxicam from Terrain Pharmaceuticals, Inc., confirming continued approval for its approved…
-
FDA approval · 2007-09-25FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen from Hikma Pharmaceuticals USA Inc., indicating an approved change or addition to the N…
-
FDA approval · 2007-07-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2007-07-26FDA Approved: NAPROXEN SODIUM — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approves Dr. Reddy's Laboratories' naproxen sodium as a generic version via an Original Abbreviated New Drug Application (ANDA). This co…
-
FDA approval · 2007-06-12FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for infliximab (Remicade) submitted by Janssen Biotech, Inc. The approval updates the labeling to re…